Mizoguchi et al., [16] have described a subpopulation of B cells called regulatory B cells (Bregs) that exhibit tumor-promoting effects by their ability to suppress T cell responses through the secretion of cytokines such as IL-10 and TGF-β as well as to upregulate immune-regulatory ligands such as PD-L1, inducing CD4+ T cell death through the expression of FasL [17,18,19]. This evidence concerns the gene IL10 and neoplasm.